Sarcura

About:

Cell Therapy transformed cancer treatment. Sarcura will transform cell therapy manufacturing.

Top Investors: HCVC, Nina Capital, xista science ventures, NovaCapital, tecnet equity

Description:

Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..

Total Funding Amount:

9.55M EUR

Headquarters Location:

Klosterneuburg, Niederosterreich, Austria

Founded Date:

2019-11-27

Contact Email:

info(AT)sarcura.com

Founders:

Daniela Buchmayr, Erwin Gorjup, Martin Fischlechner

Number of Employees:

11-50

Last Funding Date:

2022-11-17

IPO Status:

Private

Industries: